Fluoroquinolone action in mycobacteria: Similarity with effects in Escherichia coli and detection by cell lysate viscosity

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1594-1599

  Drlica, Karl ^a   Xu, Chen ^a   Wang, Jian Ying ^a   Burger, Richard M ^a   Malik, Muhammad ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CHLORAMPHENICOL; CIPROFLOXACIN; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); NALIDIXIC ACID; OXOLINIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; CELL GROWTH; DNA SYNTHESIS INHIBITION; DRUG DNA BINDING; DRUG MECHANISM; DRUG POTENCY; ESCHERICHIA COLI; MYCOBACTERIOSIS; MYCOBACTERIUM SMEGMATIS; PRIORITY JOURNAL; VISCOMETRY;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DNA DAMAGE; DNA, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; VISCOSITY;

EID: 0029950953     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Adams, D., E. Shekhtman, E. Zechiedrich, M. Schmid, and N. Cozzarelli. 1992. The role of topoisomerase IV in partitioning bacterial replicons and the structure of catenated intermediates in DNA replication. Cell 71:277-288.
2. Chen, C.-R., M. Malik, M. Snyder, and K. Drlica. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J. Mol. Biol., in press.
3. Chow, R., T. Dougherty, H. Fraimow, E. Bellin, and M. Miller. 1988. Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12. Antimicrob. Agents Chemother. 32:1113-1118.
4. Crumplin, G. C., and J. T. Smith. 1975. Nalidixic acid: an antibacterial paradox. Antimicrob. Agents Chemother. 8:251-261.
5. Deitz, W. H., T. M. Cook, and W. A. Goss. 1966. Mechanism of action of nalidixic acid on Escherickia coli. III. Conditions required for lethality. J. Bacteriol. 91:768-773.
6. Drlica, K., M. Malik, J.-Y. Wang, R. Levitz, and R. Burger. 1995. The fluoroquinolones as antituberculosis agents, p. 817-827. In W. Rom and S. Garay (ed.), Tuberculosis. Little, Brown, & Co., Boston.
7. Drlica, K., S. H. Manes, and E. C. Engle. 1980. DNA gyrase on the bacterial chromosome: possibility of two levels of action. Proc. Natl. Acad. Sci. USA 77:6879-6883.
8. Drlica, K., and M. Snyder. 1978. Superhelical Escherichia coli DNA: relaxation by coumermycin. J. Mol. Biol. 120:145-154.
9. Drlica, K., and A. Worcel. 1975. Conformational transitions in the Escherichia coli chromosome: analysis by viscometry and sedimentation. J. Mol. Bull. 98:393-411.
10. Engle, E. C., S. H. Manes, and K. Drlica. 1982. Differential effects of antibiotics inhibiting gyrase. J. Bacteriol. 149:92-98.
11. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
12. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aurais DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
13. Frieden, T., T. Sterling, A. Pablos-Mendez, J. Kilburn, G. Cauthen, and S. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526.
14. Gellert, M., K. Mizuuchi, M. H. O'Dea, T. Itoh, and J.-I. Tomizawa. 1977. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. USA 74:4772-4776.
15. Gellert, M., M. H. O'Dea, T. Itoh, and J.-I. Tomizawa. 1976. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc. Natl. Acad. Sci. USA 73:4474-4478.
16. Jacobs, W. R., G. V. Kalpana, J. D. Cirillo, L. Pascopella, S. B. Snapper, R. A. Udani, W. Jones, R. G. Barletta, and B. R. Bloom. 1991. Genetic systems in mycobacteria. Methods Enzymol. 294:537-555.
17. Kato, J.-I., Y. Nishimura, R. Imamura, H. Niki, S. Hiraga, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404.
18. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
19. Kreuzer, K. N., and N. R. Cozzarelli. 1979. Escherichia coli mutants thermosensitive for deoxyribonucleic acid gyrase subunit A: effects on deoxyribonucleic acid replication, transcription, and bacteriophage growth. J. Bacteriol. 140:424-435.
20. Lewin, C., B. Howard, and J. T. Smith. 1991. Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase. J. Med. Microbiol. 34:19-22.
21. Lewin, C., I. Morrissey, and J. T. Smith. 1991. The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment. Eur. J. Clin. Microbiol. Infect Dis. 10:240-248.
22. Liu, L., and J. Wang. 1975. In vitro DNA synthesis on primed covalently closed double-stranded templates. I. Studies with Escherichia coli DNA polymerase 1, p. 38-63. In M. Goulian, P. Hanawalt, and C. F. Fox (ed.), DNA synthesis and its regulation. Benjamin Cummings, Menlo Park, Calif.
23. Miller, J. H. 1972. Experiments in molecular genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
24. Pruss, G., R. Franco, S. Chevalier, S. Manes, and K. Drlica. 1986. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants. J. Bacteriol. 168:276-282.
25. Snyder, M., and K. Drlica. 1979. DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid. J. Mol. Biol. 131:287-302.
26. Sternglanz, R., S. DiNardo, K. A. Voelkel, Y. Nishimura, Y. Hirota, A. K. Becherer, L. Zumstein, and J. C. Wang. 1981. Mutations in the gene coding for Escherichia coli DNA topoisomerase I affecting transcription and transposition. Proc. Natl. Acad. Sci. USA 78:2747-2751.
27. Sugino, A., C. Peebles, K. Kruezer, and N. Cozzarelli. 1977. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc. Natl. Acad. Sci. USA 74:4767-4771.
28. Sullivan, E. A., B. N. Kreiswirth, L. Palumbo, V. Kapur, J. M. Musser, A. Ebrahimzadeh, and T. R. Frieden. 1995. Emergence of fluoroquinolone-resistant tuberculosis in New York City. Lancet 345:1148-1150.
29. Takiff, H., L. Salazar, C. Guerrero, W. Huang, B. Kreiswirth, S. Cole, W. Jacobs, and A. Telenti. 1994. Cloning and nucleotide sequence of the Mycobacterium tuberculosis gyrA and gyrB genes and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
30. Xu, C., B. N. Kreiswirth, S. Sreevantsan, J. M. Musser, and K. Drlica. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug resistant Mycobacterium tuberculosis. Submitted for publication.